NCCN guidelines strongly recommend broad-panel Next-Generation Sequencing (NGS) to identify actionable genomic alterations in advanced, metastatic, or high-risk cancers, particularly for NSCLC, breast, and gastrointestinal tumors
No results found!
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Pre-analytical considerations, tissue requirements and FFPE quality factors that drive successful tissue NGS.
NCCN guidelines strongly recommend broad-panel Next-Generation Sequencing (NGS) to identify actionable genomic alterations in advanced, metastatic, or high-risk cancers, particularly for NSCLC, breast, and gastrointestinal tumors
No results found!
Our oncology support team can help clinicians and patients navigate precision oncology insights — from sample logistics to interpreting actionable variants.
NABL & CAP accredited lab · Pune, India · 1800 123 12355